CIK 0001213809 · Non-accelerated filer<br>Smaller reporting company
DYADIC INTERNATIONAL INC
Sign in to watch- Ticker
- DYAI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450486747
- Phone
- 561-743-8333
- Business address
- 1044 NORTH U.S. HIGHWAY ONE, SUITE 201, JUPITER, FL, 33477
- Former names
- CCP WORLDWIDE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-10 | Bose Arindam Director | Grant or award · Stock Option | +25,000 | 25,000 | ||
| 2022-01-28 | HERBST SETH Director | Option exercise | +25,000 | $1.21 | $30K | 25,000 |
| 2022-01-28 | HERBST SETH Director | Option exercise · Stock Option | −25,000 | 25,000 | ||
| 2022-01-03 | Bose Arindam Director | Grant or award · Stock Option | +52,500 | 52,500 | ||
| 2022-01-03 | Buckland Barry Director | Grant or award · Stock Option | +35,000 | 35,000 | ||
| 2022-01-03 | EMALFARB MARK A President and CEO | Grant or award · Stock Option | +200,000 | 200,000 | ||
| 2022-01-03 | Hazelton Joseph P Chief Business Officer | Grant or award · Stock Option | +12,500 | 12,500 | ||
| 2022-01-03 | HERBST SETH Director | Grant or award · Stock Option | +35,000 | 35,000 | ||
| 2022-01-03 | Kaye Jack Director | Grant or award · Stock Option | +52,500 | 52,500 | ||
| 2022-01-03 | Lucy Patrick K. Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2022-01-03 | Rawson Ping Wang Chief Financial Officer | Grant or award · Stock Option | +75,000 | 75,000 | ||
| 2022-01-03 | Tarnok Michael P. Director | Grant or award · Stock Option | +52,500 | 52,500 | ||
| 2022-01-03 | TCHELET RONEN VP of Research and Bus. Dvlpmt | Grant or award · Stock Option | +37,500 | 37,500 | ||
| 2021-12-23 | EMALFARB MARK A President and CEO | Sale | −28,767 | $4.10 | $118K | 4,244,015 |
| 2021-12-23 | EMALFARB MARK A President and CEO | Option exercise | +150,000 | $1.63 | $245K | 4,394,015 |
| 2021-12-23 | EMALFARB MARK A President and CEO | Option exercise · Stock Option | −150,000 | 0 | ||
| 2021-12-22 | EMALFARB MARK A President and CEO | Sale | −35,649 | $4.12 | $147K | 4,272,782 |
| 2021-12-21 | EMALFARB MARK A President and CEO | Sale | −26,486 | $4.33 | $115K | 4,308,431 |
| 2021-08-11 | Francisco Trust under agreement dated February 28, 1996 10% owner | Sale | −150,000 | $5.14 | $771K | 3,548,528 |
| 2021-08-11 | Francisco Trust under agreement dated February 28, 1996 10% owner | Sale | −150,000 | $770,983.56 | $115.6B | 3,548,528 |
Page 9 of 11 · 217 trades